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amplicon-sequencing in transiently transfected and stimulated human cells. The self-
barcoding nature of each construct enables quantification of differential mRNA levels without
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tetracycline- and guanine-responsive ON- and OFF-switches based on hammerhead,
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rtificial aptazyme riboswitches are fusions of a ligand-
binding RNA aptamer and a self-cleaving ribozyme.
Conditional cleavage is mediated by binding of a specific
ligand by the aptamer domain and subsequent conformational
changes in riboswitch architecture. Riboswitches can be encoded
into DNA, e.g., in the 3′-untranslated region (UTR) upstream of a
poly(A) signal of an expression construct to conditionally cleave
the mRNA transcript1. Self-cleavage within the 3′-UTR can be
exploited for the post-transcriptional control of gene expression
by decreasing mRNA stability via conditional poly(A) tail clea-
vage. Utilization of riboswitches to control gene expression has
been demonstrated in cells2–4, C. elegans5 and in a viral vector-
mediated fashion in mice6,7. In addition to ribozyme-based
switches, further synthetic mechanisms for gene expression
control have been described in recent years including splicing
control8 and microRNA switches9. Due to their mRNA-intrinsic
mode-of-action, independence of additionally expressed (poten-
tially immunogenic) regulators, their small size and adaptability
to various ligands, riboswitches represent an attractive technology
for the development of gene expression control systems for viral
vector gene therapy. Yet, to fully exploit their potential, optimized
riboswitch designs enabling potent regulation in response to
clinically applicable ligands are required.
To identify and optimize functional riboswitch designs, arti-
ficial riboswitch sequences are usually mutated at defined
positions, e.g., within the linker sequence (also called the com-
munication module) that connects the aptamer and effector
domains. Riboswitch sequences are then screened for their
activity, either by direct assessment of self-cleavage in in vitro
transcription-based experiments (in the case of aptazymes) or
by measuring the expression of riboswitch-regulated reporter
proteins in bacteria, yeast or cell culture. Historically, these
assessments have been conducted on the level of individual
constructs, thereby limiting throughput to a maximum of a
few hundred constructs, which can be tested by hand. More
recently, higher-throughput methods have been described in
yeast10 and human cell culture11; however, these methods
rely on time-, labor- and cost-intensive FACS-sorting or gel-
electrophoretic pre-selection steps and sequence barcoding,
respectively. Therefore, there is a high need for straightforward,
time- and cost-effective screening methods to enable systematic
assessment of different riboswitch design features in human
cells, including new combinations of aptamers and ribozymes as
well as communication module sequence, length, and symmetry.
Here we introduce a fast and generally applicable method for the
identification of functional riboswitches in human cells, based on
the detection of differences in mRNA levels by deep sequencing
(Fig. 1). More specifically, following transfection of a plasmid-
based riboswitch library in human HEK-293 cells and incubation
in presence or absence of a ligand, RNA is extracted and reverse
transcribed into cDNA. The primer binding site-flanked riboswitch
sequence is PCR-amplified and analyzed by cDNA amplicon-seq.
Because each riboswitch construct in a synthetic library is char-
acterized by at least one single point mutation compared to
every other sequence, each construct is self-barcoding, dismissing
the need for additional cDNA manipulation steps. Differential
mRNA levels (stimulated vs. unstimulated) are finally calculated
and riboswitch sequences exhibiting desired expression changes are
identified.
To establish this method and to demonstrate its ability to
identify functional riboswitch constructs, we first screened libraries
based on previously described tetracycline (Tet)-hammerhead
(HHR), guanine (Gua)-hepatitis-delta-virus (HDV) and Gua-
hammerhead ribozyme designs4,12,13. Using this approach, we
recovered known and identified new Tet-responsive ON- as well as
Gua-responsive OFF- and ON-switch sequences, respectively. In
order to further validate the method’s utility for the selection of
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Fig. 1 Principle and schematic workflow for the sequencing-based identification of functional riboswitches in human cells. a HEK-293 cells are
transfected with a plasmid library harboring PCR-binding site (red arrowheads)-flanked aptazyme variants with a randomized motif (here: tetracycline
(Tet)-hammerhead design). b Functional ON-switches are characterized by aptazyme auto-cleavage and mRNA-degradation in the absence of Tet,
whereas upon Tet addition, cleavage is inhibited, resulting in stable mRNA. c Following cell lysis, RNA purification and reverse transcription into cDNA,
riboswitch sequences are PCR-amplified and applied to amplicon-seq analysis. Functional sequences are identified from differential expression analyses
(stimulated vs. unstimulated). ITR, inverted terminal repeat; CMV, cytomegalovirus; GFP, green fluorescent protein; pA, polyadenylation signal.
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generated a riboswitch library by connecting the tetracycline
aptamer to the Twister ribozyme via a permutated communication
module. Remarkably, screening of the Tet-Twister riboswitch
library resulted in the identification of the first set of allosterically
controllable Twister ribozymes for gene expression control in
human cells. To demonstrate the broad applicability of our method
beyond ribozyme-based designs, we finally describe the identifi-
cation of functional constructs from a library based on a new mode
of action, namely the ligand-dependent occupation of U1-snRNP
binding sites, thereby conditionally controlling mRNA poly-
adenylation. Our amplicon-seq approach is characterized by a high
sensitivity and a low false-positive discovery rate, thereby enabling
the efficient and robust identification of RNA-based genetic
switches. Finally, by developing a tailored computational analysis
pipeline, comprehensive analyses for several quality measures, hit
selection and structure–function characterization as well as gra-
phical reporting thereof, are enabled.
Results
cDNA amplicon-seq identifies Tet-ON- and Gua-OFF-switches.
To establish our screening method, we made use of a previously
reported Tet-hammerhead riboswitch design published by
Beilstein and colleagues (ref. 4 and Fig. 2a). This design is based
on the fusion of the Tet aptamer14 via its P1 stem to stem 1 of the
full-length hammerhead N79 ribozyme15. Within the commu-
nication module connecting the aptamer and ribozyme, Beilstein
and colleagues had altered up to five nucleotides on the 5′-strand
and two on the 3′-strand based on mechanistic considerations to
construct gene expression-inducing ON-switches (ref. 4 and
Fig. 2a). In their experiments, ten out of seventeen tested mutant
constructs demonstrated Tet-dependent functionality in HeLa
cells. Building on these results, we constructed a highly extended
library by fully randomizing the aforementioned seven nucleo-
tides, resulting in a total of 47= 16,384 constructs (Fig. 2a and
Supplementary Fig. 1a for sequence). Riboswitches were placed
into the 3′-UTR of a CMV-eGFP reporter plasmid, flanked by
(CAAA)3 spacers and synthetic PCR primer binding sites. The
plasmid library was quality-controlled by measuring the abun-
dance of each individual library plasmid construct by DNA
sequencing (Fig. 2b). Moreover, by using cDNA-amplicon-
sequencing, we confirmed that construct abundance and library
complexity were preserved after transfection into HEK-293
cells (Fig. 2c). As expected, only constructs with low initial
library abundance displayed stronger fluctuations (defined as a
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Fig. 2 Identification of Tet-responsive hammerhead ribozymes by amplicon-seq. a Secondary structure of the Tet-hammerhead ribozyme library design.
Blue nucleotides indicate the randomized motif. The arrowhead indicates the cleavage site. A/G mutation at the indicated position renders the ribozyme
inactive. b Tet riboswitch construct frequency analysis of the original library and c conservation of complexity following transfection in HEK-293 cells. CV,
coefficient of variation. d Volcano plots displaying the significance (FDR) of changes in riboswitch abundance as a function of the change in expression
(log2 fold change). e Correlation of expression induction upon Tet for constructs and associated fold changes reported by Beilstein et al.
4 (X-axis) with fold
changes measured in our screen (Y-axis). f Selected hits from the Tet riboswitch library screen, randomized sequence, mean counts per million (CPM), fold
change (FC) and false-discovery rate (FDR) at 25 and 50 µM Tet, respectively. The bar plots show the raw counts under untreated, 25 µM and 50 µM Tet-
stimulated conditions (three groups from left to right, n= 8 replicates each). g Functional hit validation in HEK-293 cells (n= 3 experiments, mean ± s.d.);
Hh-act/inact: constitutively active/inactive ribozyme control. h Maximal fold changes and p-values measured upon stimulation vs. 0 µM Tet for all tested
constructs. *p < 0.05, **p < 0.01, ***p < 0.001 (unpaired T-Test, two-tailed). Source data are provided as a Source Data file.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14491-x ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:714 | https://doi.org/10.1038/s41467-020-14491-x | www.nature.com/naturecommunications 3
post-transfection, whereas a high library-wide correlation (ρ=
0.9952) was observed (Fig. 2c).
To identify functional riboswitches, HEK-293 cells were
transfected with the library and cultivated for 48 h, before
tetracycline was added to the cells at increasing concentrations
(25 and 50 µM). After 3 h of stimulation, cells were lysed and
RNA was purified using silica column purification, including
thorough DNA depletion. Following reverse transcription and
non-saturating PCR-amplification of riboswitch sequences, PCR
amplicons were purified, quality-controlled using the Fragment
analyzer device and applied to sequencing library preparation.
cDNA-amplicon-seq was conducted on an Illumina NextSeq 500
using 10 million single-end reads of 154 bp length per sample.
cDNA-amplicon-seq functional screening data were analyzed
by first normalizing all constructs′ cDNA amplicon counts to
a control plasmid co-transfected with the library and then
comparing the normalized counts of each riboswitch construct in
presence vs. absence of ligand. Differential expression (i.e., fold-
changes and Benjamini-Hochberg adjusted p-values/false-dis-
covery rates (FDR)) was calculated, indicating enrichment of
ON-switches with increasing Tet-dose (Fig. 2d) and rankings
were generated based on the calculated expression changes at
each Tet concentration. Dose-dependency was interpreted as an
additional confidence factor.
Interestingly, among the top ranking hits based on the fold
change upon stimulation with 50 µM Tet (i.e., on rank 17 out of
16,384), we found the “K19” variant, which was the most
powerful Tet-hammerhead riboswitch identified by Beilstein et al.
in their study (see top 100 in Supplementary Table 1)4. Moreover,
a high Tet dose-dependent correlation between the originally
reported expression changes and those measured in our screen
was found for all previously reported functional constructs
present in our library (Fig. 2e). Out of the hit list we selected the
ten constructs showing the highest fold changes at 25 and 50 µM
Tet each (FDR < 20%). After removal of three duplicate hits and
three of four constructs with an AT-content >70% that was
predicted to disturb overall riboswitch structure (construct V12
was kept due to the GTA-motif that seemed to be enriched
among the selected hits), 14 constructs remained and were
applied to functional validation in HEK-293 cells (Fig. 2f). Upon
individual transfection and addition of increasing Tet doses, 10 of
these constructs exhibited Tet dose-dependent induction of
gene expression at varying potency (Fig. 2g), corresponding to
a true positive rate of 71.4%. Expression was normalized to a
conventional, riboswitch-free CMV-eGFP construct and addi-
tionally compared to K19 and constitutively active and inactive
ribozyme variants. While K19 showed 2.08-fold induction
across three experiments, the other constructs demonstrated
maximal dynamic ranges of 1.39–2.52-fold (Fig. 2h). The three
non-functional constructs displayed strongly reduced basal
eGFP expression, indicative of constitutive ribozyme activity.
Notably, two of these constructs had a screening FDR value > 0.1,
suggesting that this cutoff is important during hit selection. In
fact, if that cutoff would have been applied, the true positive rate
would have further increased to 83.3%, as opposed to 58.8%
(10/17 constructs) reported for manual testing. Notably, despite
the identification of several riboswitch variants with different
basal expression levels and dissimilar dynamic ranges, only one
switch with a better performance, i.e. a higher dynamic range
than K19, was identified in this screen. This finding demonstrates
that the chosen design, but not the screening approach, in
general, is the limiting factor for switch potency. Interestingly, the
most potent construct (V1) differed from K19 only by a single
nucleotide substitution. A high sequence similarity was also
observed for many of the other functional sequences identified in
this screen (Fig. 2f).
To demonstrate the method’s ability to identify functional
constructs, independent of the aptamer or ribozyme used, we next
screened a library based on a Gua-responsive hepatitis-delta-virus
(HDV) aptazyme design previously described by the Yokobayashi
group12 (Fig. 3a and Supplementary Fig. 1b for sequence). We
fully randomized the previously described 6-bp motif within the
communication module, resulting in a library diversity of 4096
constructs. Following QC (Fig. 3b), the library was screened in
HEK-293 cells in absence or presence of 30, 100, and 300 µM
guanine. Differential expression analysis indicated a guanine
dose-dependent enrichment of OFF-switch sequences (Fig. 3c).
Strikingly, the GuaM8HDV construct, which represented the
most powerful switch reported in the original paper was also
identified as the top hit in our screen (Fig. 3d). Moreover, the top
60 constructs in our screen (based on the log2FC at 300 µM
guanine, see Supplementary Table 2) also contained the five other
previously identified switches that showed a fold change of >1.4
in the original publication. In contrast, the two weakest original
variants were found on rank 3108 and 3888, respectively, out of
4096 constructs in our screen. Finally, 9 of the top 10 identified
constructs (selection criteria: log2FC <=−0.6, FDR <= 0.01,
guanine dose-dependency) showed Gua-dependent downregula-
tion of GFP expression in HEK-293 cells (Fig. 3e, f). Taken
together, our data clearly demonstrate the ability of the amplicon-
seq approach to recover known and identify new switch variants
from complex construct libraries.
cDNA-amplicon-seq identifies Gua-hammerhead ON-switches.
We next applied the amplicon-seq approach to a library based on
the guanine aptamer fused to the hammerhead type-III ribozyme
(Fig. 4a). In a previous study, we used a rational approach to
construct Gua-dependent ON-switches using this design13. Now,
we aimed to utilize amplicon-seq to explore a larger sequence
space by randomizing the communication module at seven
positions (Fig. 4a and Supplementary Fig. 1c for sequence). Fol-
lowing QC (Fig. 4b), the library was screened in HEK-293 cells in
presence or absence of 30, 100, and 300 µM guanine.
Differential expression analysis showed a guanine dose-
dependent increase for many sequences with a trend towards
higher potency for ON- vs. OFF-switches (Fig. 4c). From the hit
list ranked by logFC at 300 µM guanine (selection criteria: log2FC
>= 0.6, FDR <= 0.01, guanine dose-dependency), we selected the
seven top hits for functional validation in HEK-293 cells (Fig. 4d).
Notably, all seven constructs demonstrated potent and dose-
dependent ON-switch activity (Fig. 4e, f). The most interesting
switches in terms of fold change and dynamic range were
GuaB4HHR (5.0–34.2% of the expression levels of a conventional,
riboswitch-free construct, 6.9-fold change) and GuaB6HHR
(19.6–84.1%, 4.3-fold change). Given that the previous rationally
designed variants only showed up to 2-fold expression induc-
tion13, these results nicely demonstrate the power of our screen to
identify higher-potency switches from large sequence space.
cDNA-amplicon-seq identifies Tet-Twister aptazymes. The
recently identified Twister ribozyme represents one out of cur-
rently 9 known self-cleaving ribozyme motifs16 that can serve as
an expression platform for novel aptazymes. We have recently
shown that the Twister ribozyme is a versatile platform to con-
struct one- and two-input genetic switches in E. coli and S. cer-
evisiae17. However, no allosterically controllable riboswitches that
are functional in human cells have been described for this ribo-
zyme so far. Therefore, we next aimed to identify Tet-responsive
Twister riboswitches. We designed Tet-Twister ribozyme candi-
dates by connecting the Tet aptamer via its P2 stem to the
P1 stem of the Twister ribozyme (Fig. 5a). This design was chosen
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based on our previous finding that the connection of the aptamer
to the P1 site of the Twister ribozyme resulted in both, ON- and
OFF-switches, which showed better performance than the designs
based on connecting the aptamer to the P5 site17. Nine different
sub-libraries were generated, where the length and stability (“CG”
design, “noCG” design), symmetry and orientation of the com-
munication module were varied (Fig. 5a and Supplementary
Fig. 1d for sequence). The combination of three different lengths
(by optional inclusion of CG pairs on either side of the com-
munication module) with five (asymmetric linker, “2N3N” and
“3N2N”) or six randomized nucleotides (symmetric linker,
“3N3N”), resulted in a final library complexity of 18,432 con-
structs. Library DNA sequencing was again applied to explore
construct abundance. Due to the fact that the nine sub-libraries
were mixed at equal ratios, the finding that 3N3N constructs
were abundant at approximately four-fold lower levels than
constructs in which only 5 nucleotides were randomized (2N3N
and 3N2N), was expected (Fig. 5a, inset). The library was
screened in HEK-293 cells in absence or presence of 12.5, 25, and
50 µM Tet and construct functionality was analyzed by cDNA-
amplicon-seq. Furthermore, in order to facilitate sequencing data
processing, including quality control, data analysis and graphical
output generation, a computational processing pipeline was
built (available through GitHub, see ‘Data availability” section for
details). Among others, the quality measures included analyses of
variant abundance on a single-sample level and its dependency on
the GC-content of the randomized sequence motif. The analyses
demonstrated that sample-to-sample fluctuation was low and that
no GC-dependency (which could indicate potential biases in
library synthesis) was observed (exemplarily shown in Supple-
mentary Figs. 2 and 3).
The functional screening results clearly showed that our designs
resulted in the selection of OFF-switches, whereas only a few
motifs passed the significance threshold (|log2FC| >= 0.6, FDR <
1%) for ON-switches (Fig. 5b and exemplary pipeline output in


























































































































































































































































































































































































Fig. 3 Identification of Gua-responsive HDV ribozymes by amplicon-seq. a Secondary structure of the Gua-HDV ribozyme library design. Blue
nucleotides indicate the randomized motif. The arrowhead indicates the cleavage site. C/U mutation at the indicated position renders the ribozyme
inactive. b Guanine riboswitch construct frequency analysis of the original library. c Volcano plots displaying the significance (FDR) of changes in
riboswitch abundance as a function of the change in expression (log2 fold change). d Selected hits from the Gua-HDV riboswitch library screen,
randomized sequence, mean counts per million (CPM), fold change (FC) and false-discovery rate (FDR) at 30, 100, and 300 µM guanine, respectively. The
bar plots show the raw counts under untreated, 30, 100, and 300 µM µM Gua-stimulated conditions (four groups from left to right, n= 8 replicates each).
e Functional hit validation in HEK-293 cells at increasing guanine doses [µM] (n= 3 replicates, mean ± s.d.); HDV-act/inact: constitutively active/inactive
ribozyme control. f Maximal fold changes and p-values measured upon stimulation vs. 0 µM guanine for all tested constructs. *p < 0.05, **p < 0.01, ***p <
0.001 (unpaired T-Test, two-tailed). Source data are provided as a Source Data file.
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fold changes were observed for all 3N3N libraries compared to
2N3N and 3N2N designs further suggests that the symmetric
communication module design leads to switches of higher potency
than the asymmetric design. Moreover, the fraction of constructs
displaying higher fold changes and/or higher significance was
biggest in the “CG”-sub-libraries, suggesting that linker stabiliza-
tion by the Twister-proximal CG pair has an overall beneficial
effect. Conversely, the lower fold changes and less significant data
obtained for the majority of the “noCG” variants indicate that the
Tet aptamer-proximal CG pair is required for functionality.
Variant similarity assessment among deregulated constructs based
on Hamming distance and sequence motifs (exemplified in
Supplementary Fig. 5) or similarity network analysis (Supplemen-
tary Fig. 6) resulted in groups of candidate constructs with related
sequences.
Based on our screening results, we selected ten constructs
(Fig. 5c and annotations in Fig. 5b) for functional validation in
cells. Selected sequences were part of the top ten of each sub-
library (Supplementary Table 3) in terms of fold change and
had an FDR < 1% at more than one Tet concentration. They
further showed dose-dependency and displayed maximal log2FC
values of greater than 1.0. Upon transfection of HeLa cells and
stimulation with increasing doses of Tet, all ten candidate
constructs displayed OFF-switch activity, i.e. conditional and
concentration-dependent downregulation of reporter gene
expression (Fig. 5d). Notably, most of the “CG” design constructs
(T5-T10) indeed showed higher fold changes than the constructs
lacking the CG pair (Fig. 5e), as suggested by the screening
results (Fig. 5b, c). Furthermore, as predicted, the top performing
construct T9 was based on the symmetric 3N3N design. Finally,
similarity network analysis of the CG_3N3N sub-library
containing the T9 sequence (CCG_CAG) revealed several groups
of related sequences (Fig. 5f and Supplementary Fig. 6), serving
as a basis for future design strategies and assessment of
structure–function relationships. The observation that all ten
sequences selected for cellular characterization showed Tet-dose-
dependent control of gene expression demonstrates that the
screening approach together with the described selection criteria
results in a low false-positive hit discovery rate. This notion is
further supported by the finding that four randomly selected
constructs that did not fulfill our selection criteria (i.e., they were
found on ranks #500, #1000, #2000, and #3000 of a negative
selection list based on a log2-fold change >−0.6 and an FDR >
0.01 at 300 µM) did not show switching behavior, as expected
(Supplementary Fig. 7). In addition, the finding that switches











































































































































































































































































Fig. 4 Identification of Gua-responsive hammerhead ribozymes by amplicon-seq. a Secondary structure of the guanine hammerhead ribozyme library
design. Blue nucleotides indicate the randomized motif. The arrowhead indicates the cleavage site. A/G mutation at the indicated position renders the
ribozyme inactive. b Guanine riboswitch construct frequency analysis of the original library. c Volcano plots displaying the significance (FDR) of changes in
riboswitch abundance as a function of the change in expression (log2 fold change). d Selected hits from the Gua-HHR riboswitch library screen, randomized
sequence, mean counts per million (CPM), fold change (FC) and false-discovery rate (FDR) at 30, 100, and 300 µM guanine, respectively. The bar plots
show the raw counts under untreated, 30, 100, and 300 µM µM Gua-stimulated conditions (four groups from left to right, n= 8 replicates each).
e Functional hit validation in HEK-293 cells at increasing guanine doses [µM] (n= 3 replicates, mean ± s.d.); Hh-act/inact: constitutively active/inactive
ribozyme control. f Maximal fold changes and p-values measured upon stimulation vs. 0 µM guanine for all tested constructs. *p < 0.05, **p < 0.01, ***p <
0.001 (unpaired T-Test, two-tailed). Source data are provided as a Source Data file.
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our screens demonstrates a high sensitivity of our method. In
summary, amplicon-seq of Tet-Twister aptazymes identified the
first Twister-based OFF-switches that are functional in human
cells. Our method further allowed to systematically assess the
effect of linker stability and symmetry on overall riboswitch
function, thereby demonstrating its applicability to study RNA
design features at large scale.
Amplicon-seq enables identifying U1-snRNP-dependent
switches. In order to demonstrate the universal applicability of
the introduced amplicon-seq approach, we sought to expand our
method from the identification of functional riboswitches towards
other RNA-based platforms, beyond aptazymes. An increasing set
of synthetic riboswitch systems differing in its expression platforms
has been developed in recent years18, ranging from splicing
modulation8 to in trans systems that rely on RNA interference19.
Prerequisites for amplicon-seq-based screening of sequence
libraries based on such alternative expression platforms is a ligand-
induced change in mRNA levels and an in cis regulation that
allows for self-barcoding. Considering these requirements, we
sought to develop a platform that is based on conditional poly-
adenylation. It is known that binding of the U1 small nuclear
ribonucleoprotein (U1-snRNP) upstream of a polyadenylation site
inhibits its usage and reduces mRNA levels20,21. Consequently, the
insertion of a 9 nt long sequence (CAGGUAAGU) that is com-
plementary to the 5′ end of the U1 snRNA, into the 3′-UTR of a
CMV-eGFP construct, led to the effective reduction of GFP
reporter expression by 7.5-fold to basal expression levels of 13.3%
(U1-bs construct, see below). Fortes et al. further showed that
occlusion of such a U1-snRNP binding site in a hairpin structure
reverses the polyadenylation-inhibitory effect20. Taking these
findings into account, we included the U1-snRNP binding site into
a prolonged stem P1 of the guanine aptamer with the aim to place
the accessibility of the U1-snRNP binding site under control of
ligand binding to the aptamer (Fig. 6a and Supplementary Fig. 1e
for sequence), thereby conditionally controlling polyadenylation
and downstream gene expression (Fig. 6b). In this design, we
randomized 6 nucleotides (Fig. 6a) and, following QC (Fig. 6c),
screened the resulting library in HEK-293 cells in presence or
absence of 30, 100, and 300 µM guanine.
Differential expression analysis clearly demonstrated an
enrichment of ON-switches with increasing guanine-doses, as
expected based on the mode of action (Fig. 6d). From the hit list
ranked by log2FC at 300 µM guanine (selection criteria: FDR <=
0.01, guanine dose-dependency), we selected the top ten
constructs for functional validation in HEK-293 cells (Fig. 6e).
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Fig. 5 Identification of Tet-responsive Twister ribozymes by amplicon-seq. a Secondary structure of the Tet-Twister library design. Blue boxes indicate
the randomized motifs of the nine sub-libraries, connecting the Twister ribozyme and the Tet aptamer. The arrowhead indicates the cleavage site. GU/UG
mutation at the indicated position renders the ribozyme inactive. Inset: Library construct frequency analysis by DNA sequencing. b Volcano plots displaying
the significance (FDR) of changes in riboswitch abundance as a function of the change in expression (log2 fold change) for the nine Tet-Twister sub-
libraries. Selected hits are labeled with their sequence motif. c Selected hits from the Tet-Twister library screen, randomized sequence, mean counts per
million (CPM), fold change (FC) and false-discovery rate (FDR) at 12.5, 25, and 50 µM Tet, respectively. The bar plots show the raw counts under
untreated, 12.5, 25, and 50 µM Tet-stimulated conditions (four groups from left to right, n= 8 replicates each). d Functional hit validation in HeLa cells at
increasing tetracycline doses [µM] (n= 3 replicates, mean ± s.d.); psi-Check: ribozyme-free control construct; Tw-act/inact: constitutively active/inactive
ribozyme control. e Maximal fold changes and p-values measured upon stimulation vs. 0 µM Tet for all tested constructs. f Network analysis of motif
similarity for the CG_3N3N library at 25 µM Tet vs. untreated and an FDR < 1%. Each line segment represents a single nucleotide change. The “T9”
construct is circled in red. *p < 0.05, **p < 0.01, ***p < 0.001 (unpaired T-Test, two-tailed). Source data are provided as a Source Data file.
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dose-dependent induction of gene expression (Fig. 6f). The two
most interesting switches in terms of expression range and fold
change were GuaU1B1 (37.5–75.7%, 2.0-fold change) and
GuaU1B10 (19.1–42.7%, 2.2-fold change). These results demon-
strate that our amplicon-seq method is suitable for identifying
synthetic riboswitches based on alternative expression platforms,
thereby significantly extending its applicability for the identifica-
tion of gene expression control devices beyond aptazymes.
Finally, the developed switches based on a simplified mode of
action require even less coding space than the previously
described aptazyme-based switches (81 nucleotides, including
the ligand-binding aptamer and the expression platform), making
them particularly attractive candidates for applications where
expression cassette size is a limiting factor.
Discussion
In the present work, we describe a fast, sensitive and easy-to-
implement approach for the identification of artificial, ligand-
responsive riboswitches in human cells in a high-throughput
manner. By applying cDNA-amplicon-seq-based counting of
conditionally expressed mRNAs, functional riboswitch candidates
can be rapidly identified from complex libraries containing several
thousand constructs, thereby enabling the exploration of large
sequence spaces. Using this method, we identified tetracycline-
and guanine-inducible hammerhead and HDV riboswitches,
allosterically controllable Twister-riboswitches for use in human
cells and finally, switches using a mode of action based on the
conditional modulation of U1-snRNP-dependent polyadenylation.
Our initial approach was based on the fact that functional
aptazyme riboswitch sequences within a gene expression con-
struct lead to the conditional, ligand-dependent cleavage and
subsequent cellular degradation of the mRNA in which they are
encoded. Due to the mRNA-intrinsic mode of action, the abun-
dance and identity of riboswitch candidate sequences is directly
linked to their function. A similar concept was previously applied
to identify enhancer elements on a whole-genome scale, by
cloning enhancer candidate libraries into reporter plasmids and



















































































































































































































































































































































Fig. 6 Identification of Gua-responsive riboswitches based on a U1-snRNP-dependent mode of action. a Secondary structure of the Gua-U1-snRNP
riboswitch library design. The U1-snRNP binding site (CAGGUAAGU) is included into a prolonged stem P1 of the guanine aptamer. Blue nucleotides
indicate the randomized motif. b Mode of action of U1-snRNP-dependent riboswitches. In the ligand-unbound conformation, the U1-snRNP binding site is
available, allowing for U1-snRNP binding and interference with the polyadenylation process. Upon ligand binding, the aptamer stem is stabilized and the U1-
snRNP binding site is masked, enabling polyadenylation and subsequent gene expression. c Guanine riboswitch construct frequency analysis of the original
library. d Volcano plots showing the significance (FDR) of changes in riboswitch abundance as a function of the change in expression (log2 fold change).
e Selected hits from the Gua-U1-snRNP riboswitch library screen, randomized sequence, mean counts per million (CPM), fold change (FC) and false-
discovery rate (FDR) at 30, 100, and 300 µM guanine, respectively. The bar plots show the raw counts under untreated, 30, 100, and 300 µM µM Gua-
stimulated conditions (four groups from left to right, n= 8 replicates each). f Functional hit validation in HEK-293 cells at increasing guanine doses [µM]
(n= 3 replicates, mean ± s.d.); U1-bs: construct harboring the freely accessible U1-snRNP binding site. g Maximal fold changes and p-values measured
upon stimulation vs. 0 µM guanine for all tested constructs. *p < 0.05, **p < 0.01, ***p < 0.001 (unpaired T-Test, two-tailed). Source data are provided as a
Source Data file.
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This method is known as “self-transcribing active regulatory
region sequencing” (STARR-seq)22. Recently, efforts have also
been undertaken in the field of ribozyme and riboswitch engi-
neering, to establish high-throughput screening methods. Town-
shend and colleagues developed a method allowing screening of
construct libraries in yeast10. However, this method relied on
FACS-selection to generate several bins of low- to high-expressing
constructs prior to the sequencing-based identification of func-
tional sequences. Moreover, their method required expensive
sequence barcoding and has not yet been shown to be transfer-
rable to human cells. More recently, the Yokobayashi group
published a series of papers, utilizing sequencing of in vitro-
transcribed constructs to analyze cleavage of Twister-, HDV-like
drz-Agam-2-1- and Pistol ribozyme variants23–25. They further
described a strategy for the identification of functional constructs
in cells11. However, that method requires the isolated RNA to be
separated into a non-cleaved and cleaved fraction by gel electro-
phoresis prior to sequencing, which again, is labor-intensive, more
difficult to implement and potentially error-prone. In contrast, the
method described in our work enables the rapid identification of
conditionally cleaving aptazymes in a relevant cellular system, like
e.g. the human cell line HEK-293, in a high-throughput manner,
independent of additional pre-selection steps and costly sequence
barcoding. The method relies on five core steps, namely library
transfection, RNA extraction, cDNA synthesis, PCR amplification
and sequencing, and enables direct screening for mRNA self-
cleavage in libraries harboring up to approximately 18,000 con-
structs. Interestingly, while preparing our manuscript, the Smolke
lab published a similar method that also successfully applies
cDNA-sequencing to identify riboswitches26. In contrast to our
method, which exploits the inherent self-barcoding nature of
permutated sequence, the method described by Xiang et al.
requires an additional sequence barcoding step26. Moreover, while
both approaches underscore the applicability and value of cDNA-
amplicon-sequencing for the discovery of gene switches based on
ribozyme platforms, the data presented in our study further
extend the use of this method towards expression platforms
beyond ribozymes, as demonstrated by the U1-snRNP library
screen.
A general advantage of the amplicon-seq approach is an
apparent high sensitivity of detection. Many identified switches
show rather low switching performance and might therefore easily
be missed with alternative methods based on pre-selection, such as
FACS-based techniques. Moreover, although the screening of the
Tet-hammerhead- and Twister-aptazymes in the present work
yielded only sequences with intermediate to low switching per-
formances, such sequences could still be valuable, in part due to
apparent differences in potency depending on the experimental
context. In fact, it seems that the performance of the switches is
underestimated in our setup. For example, the K19 sequence that
has been rationally designed by the Süß group was originally
reported to switch 4.8-fold4. However, we re-discovered the switch
in our library and in our context the sequence switches only 2.08-
fold. A likely explanation is that the sequence context alters the
performance of the ribozyme switches in general. This inter-
pretation is supported by the finding that the constitutively active
hammerhead (Fig. 2g) and, even more pronounced, the active
Twister ribozyme (Fig. 5d) both show considerable background
in our setup, thereby likely limiting the maximum dynamic range
the identified switches can achieve in our constructs. Notably,
recently reported data still suggest that such switches can be useful
in diverse applications, e.g., we have recently shown that the Tet
K19 switch and its derivatives enable robust switching of gene
expression in the nematode C. elegans5. In addition, we have
demonstrated that the K19 sequence is also able to conditionally
induce gene expression up to 15-fold in mice, when a secreted
antibody-derivative was expressed using AAV-vector-mediated
delivery of the transgene (Strobel et al., 2019, manuscript sub-
mitted). Importantly, these findings suggest that switches identi-
fied in our screen, such as the Tet-hammerhead V1 construct,
which showed a 21% higher dynamic range than K19, might prove
significantly more powerful in a different context, e.g. when
applied to control expression in mice.
Besides Tet-hammerhead, Gua-HDV and Tet-Twister-based
switches, we have also identified functional Gua-responsive
hammerhead and U1-snRNP switches. The finding that power-
ful Gua-HHR ON-switches were identified (up to 6.9-fold
induction) not only demonstrates the high value of the amplicon-
seq approach for the mining of large sequence space, but also
fuels hopes for the development of even higher-potency switches
that would ultimately be required for therapeutic applications.
Along those lines, two features of the U1-snRNP approach render
it particularly attractive: First, the mode of action is simpler than
that of aptazymes and second, even less coding space is required
—an important characteristic, in particular in the case of AAV
vectors that would profit from small and efficient gene expression
control devices for future uses in gene therapy.
While a straightforward approach, several aspects requiring
particular consideration to assure successful screening runs were
identified during the setup of our method, which are worth to be
discussed in more detail. First, constructs within a library should
be available at similar abundance. This can be assured by both,
monitoring library complexity during cloning/bacterial amplifi-
cation of library cultures and (Sanger-) sequencing-based analysis
of random samples during these process stages to estimate library
complexity, and by deep sequencing analysis of the final library
prior to screening run initiation. In fact, in our hands, an initial
Tet-hammerhead screening run had led to a false-positive
enrichment of AT-rich sequences, which retrospectively turned
out to be due to a systematic underrepresentation of GC-rich
sequences owing to an unintentional bias at random positions
during the process of the oligonucleotide library synthesis. A GC-
dependency test and graphical output (Supplementary Fig. 3) has
therefore been implemented into the computational pipeline
provided with this manuscript. Second, to avoid PCR amplifica-
tion of riboswitch sequences from residual plasmid DNA rather
than cDNA, thorough depletion of plasmid DNA during RNA
isolation needs to be assured (see Methods section), while RNA
integrity needs to preserved. Third, PCR should be optimized
for non-saturating conditions to preserve the relative levels of
each mRNA/cDNA construct. However, the necessity for PCR
amplification of riboswitches from cDNA might also become
obsolete by using targeted reverse transcription into cDNA
(instead of random priming26), which will be assessed in our lab
in upcoming screening runs. Fourth, when analyzing amplicon-
sequencing data and selecting hits, one might encounter the well-
known phenomenon that constructs of relatively low library
abundance tend to show comparably high expression changes,
whereas constructs with high library abundance might show
highly significant p-values but lower fold changes (exemplified
in Supplementary Fig. 8). It is therefore recommended to assess
the sequencing counts during hit selection. The combination
of fold changes and p-values into a common “pi-score”, which
was suggested to show better protection against false dis-
coveries27, represents an alternative selection approach (compare
Supplementary Fig. 9). Finally, while we mostly observed good
correlation between amplicon-seq-derived fold changes and
those derived from cell culture experiments (Supplementary
Fig. 10), still a few constructs behaved differently and/or turned
out to be false-positive screening hits. While in case of the Tet-
hammerhead run, low overall construct abundance and a less
stringent FDR cutoff are likely to explain the occurrence of the
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three false-positive hits, the one false-positive construct in the
context of the Gua-HDV library cannot be explained. Of note,
while the earliest screening run (Tet-HHR) in general showed
higher fluctuations and lower correlation, the data of all following
runs were significantly more robust and revealed only little (10%,
Gua-HDV) or no false-positives (Gua-HHR, Tet-Twister, Gua-
U1-snRNP). These findings suggest that subtle method optimi-
zation steps (e.g., using three compound doses to facilitate dose-
dependency assessment), library QC and proper FDR cutoff
selection help to minimize false-positive discoveries.
The method described herein offers a straightforward approach
to identify functional riboswitch constructs in the human cellular
context, thereby reducing the risk of limited cross-species trans-
latability, as often observed with screening approaches in bacteria
or yeast in the past28,29. It is conceivable that this method should
also be easily transferrable to other experimental systems,
including human primary cells and even in vivo models, to fur-
ther increase the translational relevance or identify switches that
act in a more cell-specific fashion. In particular, screening of
riboswitches in mice by, e.g., AAV-mediated library expression
(as already established in the context of AAV engineering30,31)
and subsequent amplicon-seq analysis of tissue-derived RNA, has
the potential to explore organ-specific riboswitch behavior,
establish pharmacokinetic-pharmacodynamic relationships and
therefore ultimately contribute to the identification of switches
for therapeutic use.
In summary, our comparatively easy-to-implement method
enables the fast and efficient identification of synthetic ribos-
witches from complex construct libraries, thereby overcoming
one of the major hurdles on the way to therapeutically applicable
switches for gene expression control.
Methods
Cell culture, expression plasmids, and riboswitch libraries. HEK-293h (Thermo
Fisher Scientific, cat. no. 11631017) and HeLa cells (ATCC, cat. no. ATCC-CCL-2)
were cultured in Dulbecco’s modified Eagle’s medium (DMEM)+GlutaMAX-I+
10% fetal calf serum (Gibco/Thermo Fisher Scientific), optionally supplemented
with 1% Penicillin/Streptomycin in a humidified incubator at 37 °C and 5% CO2.
Cells were routinely grown in standard T175 flasks (Sarstedt). The expression
plasmid used for riboswitch screening and functional construct validation con-
tained AAV2-inverted terminal repeat (ITR) sequences flanking a CMV promoter-
eGFP-SV40-poly(A) cassette with HindIII and BglII restriction sites between the
eGFP gene and the poly(A)-signal for riboswitch insertion. Riboswitch sequences
were flanked by the following primer binding sites in 5′-3′ direction: forward:
cattgcagcgtattcccagtcc, reverse: gcctggtgaaattgttatccgct. Exemplary sequences are
provided in Supplementary Fig. 1. Tet-HHR and Tet-Twister riboswitch mutant
libraries were synthesized at GeneArt (Thermo Fisher Scientific) based on the
assembly of synthetic degenerated oligonucleotides, followed by PCR amplification,
cloning into the desired CMV-eGFP expression plasmid backbone and amplifica-
tion in E. coli DH10b. Library complexity and nucleotide distribution at specific
positions within the randomized sequence was estimated by GeneArt, based on
sequence analysis of 48 bacterial clones picked at the stage of library transforma-
tion in E. coli. Gua-HDV, Gua-HHR and Gua-U1-snRNP libraries were first cloned
using degenerated oligonucleotides on a pET11a plasmid. After inserting the
respective ribozyme and/or primer binding sites, the guanine aptamer was added
by whole-plasmid PCR using a Phusion Hot Start 2 Polymerase (NEB) with pri-
mers harboring the aptamer and the respective randomized communication
module in 5′ overhangs (Integrated DNA Technologies, “hand-mixing” option).
The template was digested with DpnI (NEB) and the PCR product was purified by
gel electrophoresis and recovered with the Zymoclean Gel DNA Recovery Kit. The
DNA was circularized with Quick Ligase (NEB) and concentrated using the Clean
and Concentrate Kit (Zymo Research). The constructs were then PCR amplified,
cloned into the desired CMV-eGFP expression plasmid backbone using HindIII
and BglII and transformed into E. coli XL10 gold (Stratagene). The bacteria were
grown overnight at 37 °C on LB agar plates containing 100 μg/mL Carbenicillin. To
maintain library complexity, a number of colonies exceeding 17-fold of the library
size was scraped off the plates. Plasmids were isolated and sequenced at Eurofins
Genomics/GATC Biotech. For Twister sequence candidate validation, sequences
were cloned into the 3′-UTR of the Renilla luciferase (hRluc) on the psiCHECK-2
plasmid (Promega) while the firefly luciferase (hluc+) served as transfection
control. After inserting a Twister ribozyme into the 3′-UTR of hRluc, the tetra-
cycline aptamer was added by whole-plasmid PCR using the procedure described
above. All cloning primers used in this study are listed in Supplementary Table 4.
Screening step 1: transfection and stimulation. Twenty-four hours before
transfection, HEK-293 cells were seeded into 12-well plates at a density of 310.000
cells/well in 1 mL media. The next day (at a desired confluency of 70–80%),
transfection mixtures were prepared by combining 50 µL OptiMEM media with
1.5 µL Lipofectamine-3000 (both Thermo Fisher Scientific) and another 50 µL
OptiMEM with 1.2 µL P3000 and 600 ng of riboswitch library DNA. After mixing
the two preparations and incubation for 10 min, 100 µL transfection mix were
added to the cells. For a screening assay comprising eight replicates of each, control
and three doses of ligand-treatment (n= 32), the amounts of all reagents and DNA
were linearly upscaled (e.g., 19.2 µg DNA were used). In cases were large volumes
of library DNA had to be used because of low concentrations, the volume of
OptiMEM was reduced accordingly. Tetracycline (Sigma-Aldrich) was usually
stored frozen as a 50 mM stock solution in light-protected tubes. Before use, it was
thawed and diluted 1:10 in water (=5 mM). This solution was then used to prepare
cell culture media at 12.5, 25 or 50 µM final Tet concentration. Guanine (Sigma-
Aldrich) was dissolved in 0.1 M NaOH at 20 mM and diluted to the desired
concentration in cell culture medium. Forty-eight hours after transfection, media
was gently aspirated from the cells and Tet- or Gua-containing media was carefully
added to the cells. To avoid prolonged periods without media, media was con-
secutively exchanged in maximally four wells at a time, going stepwise from cells
receiving Tet/Gua-free to increasing doses of Tet/Gua-containing media. Stepper
pipettes were used at low speed to facilitate gentle and uniform media dispensing.
The cells were then incubated for three hours at 37 °C.
Screening step 2: RNA purification. Three hours after ligand addition, media was
aspirated gently and 500 µL ice-cold phosphate-buffered saline (PBS) was pipetted
onto the cells. Cells were detached by pipetting, transferred to 1.5 mL reaction
tubes and placed on ice. After harvesting all wells, cells were pelleted by cen-
trifugation at 700 × g for 3 min. The supernatant was carefully but thoroughly
aspirated. 370 µL RLT buffer (Qiagen) were then added to the cells, vortexed and
incubated at RT for 3–5 min to facilitate lysis. After centrifugation of the cell lysates
for 3 min at 10,000 × g, 300 µL supernatant of each sample were thoroughly mixed
with 300 µL 70% ethanol and transferred to an RNeasy 96 plate (Qiagen). RNA was
purified according to the manufacturer’s instructions, including the optional on-
column DNase step with an incubation for 25 min at RT, as described in the
RNeasy 96 kit manual. RNA was finally eluted by two consecutive elution steps,
using 45 µL RNAse-free water each. A 10-minute in-solution DNase step was
carried out to deplete residual DNA as per protocol (see Qiagen RNeasy MinElute
Cleanup kit manual), followed by RNA cleanup as per RNeasy 96 kit protocol. In
general, whenever possible, multichannel or stepper pipettes were used to facilitate
speedy RNA purification and decrease the risk of RNA degradation. RNA con-
centration was determined spectrophotometrically, using NanoDrop devices.
Screening steps 3–4: reverse transcription, PCR amplification. One microgram
of each RNA sample was then used as a template for reverse transcription into
cDNA, using the High capacity cDNA Reverse Transcription Kit (Applied Bio-
systems, Thermo Fisher Scientific) and a reaction volume of 40 µL. In addition,
non-transcription control reactions that lacked the reverse transcriptase were
prepared. Following the instructions of the kit manual, reverse transcription was
conducted in a PCR cycle for 10 min at 25 °C, 120 min at 37 °C and 5 min at 85 °C.
After cooling down the samples to 4 °C, 1 µL of each reaction (usually corre-
sponding to approximately 2.3 µg cDNA, as assessed per Nanodrop) was trans-
ferred to a PCR plate for riboswitch sequence amplification, using following
primers: RS-ampl-forward (5′3′): cattgcagcgtattcccagtcc, RS-ampl-reverse (5′3′):
agcggataacaatttcaccaggc. For each reaction, the cDNA was mixed with 4 µL 5×
Phusion Buffer HT (Thermo Fisher Scientific), 0.4 µL dNTPs (10 mM stock), 1 µL
of both, forward and reverse primers (10 µM stock), 0.5 µL Phusion Enzyme
(2U/µL) and 12.1 µL H2O. Because a usual experiment comprised 32 samples, the
PCR mix was usually set up as a 35× master mix. PCR conditions were as follows:
30 s at 98 °C, followed by 22 cycles of 5 s at 98 °C, 10 s at 68 °C and 15 s at 72 °C,
followed by a final elongation step at 72 °C for 7 min and subsequent cooling at
10 °C. As a negative control, several RNA samples that were not reversely tran-
scribed were also PCR amplified to prove they were free of residual plasmid DNA.
PCR reactions were finally purified using the NucleoSpin Gel and PCR Clean-up
kit (Macherey-Nagel) and eluted in 20 µL H2O. Higher-throughput PCR pur-
ification was carried out using the MagMax Express-96 Magnetic Particle processor
and AMPure Beads from Beckmann Coulter according to the manufacturer’s
clean-up protocol.
Screening step 5: cDNA-amplicon-seq and hit selection. PCR product DNA
concentration was determined on the Fragment Analyzer with NGS Standard
Sensitivity according to manufacturer’s instructions. Subsequently, end repair was
carried out using the Ovation Library System for Low Complexity Samples kit
(NuGEN) with the manufacturer’s protocol, followed by adaptor ligation from the
same kit. The libraries underwent cleanup again using the MagMAX Express-96
Magnetic Particle processor and the Agencourt RNAClean XP beads (Beckmann
Coulter) following the manufacturer’s protocol. Subsequently, library amplification
was carried out using the Ovation Library System for Low Complexity Samples kit
(NuGEN) according to the manufacturer’s protocol, followed by a clean-up step
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with Agencourt AMPure XP Beads (Beckmann Coulter). The libraries were
quantified using a Quant-iT PicoGreen dsDNA Assay kit (Invitrogen) according to
the manufacturer’s instructions and fragment size was determined with the NGS
Standard Sensitivity Kit (Advanced Analytical) on a Fragment Analyzer. Based on
the concentrations obtained from the PicoGreen measurement, a 2 nM dilution of
the libraries in Illumina Resuspension Buffer+ 0.1% Tween20 preparation (Sigma)
was prepared and in the following, 10 µL of each sample were mixed with a unique
reverse adaptor from the 2 nM dilution. Libraries were denatured by consecutive
addition of 10 µL 0.2 N NaOH, µL of 200 mM Tris-HCl, pH 7.0 and 970 µL of
prechilled HT1 buffer. In a new prechilled tube, 1183 µL of prechilled HT1 buffer
were added. Subsequently, 117 µL of the library pool dilution and 2 µL of 20 pM
PhiX control were added. Finally, the libraries were sequenced on an llumina
NextSeq 500, using 10 million single-end reads of 154 bp length per sample, using
the NextSeq 500/550 High Output Kit v2.
Screening step 6: bioinformatic analyses. A program built in-house was used to
count the abundance of the different aptamer variations found in the rawdata (in
FASTQ format) from each library. The program searches for a set of patterns using
pre-defined regular expressions (see Supplementary Table 5 for an example) and
reports the sequence abundance of each variable region (random pool) in the
aptamer along with various quality control read-outs (e.g., the GC-dependence of
the abundance distribution, Supplementary Fig. 3). Sequence abundance was then
normalized with respect to a spike-in sequence present in the same concentration
in all libraries. The edgeR32 package in R33 was used to identify significant changes
in pattern abundance in the different treatment conditions, and for summarizing
the results in volcano plots for each of the contrasts (Supplementary Fig. 4). The
sequences of significantly changed variants were further subjected to a variety of
sequence similarity analyses. For this, similar sequences were first identified by
calculating the Hamming distance between them, and calculating the hierarchical
cluster on those distances, cutting the tree at a height of 0.75 (which would group
sequences with >75% identity) (Supplementary Fig. 5a). By using the package
motifStack34, a position weight matrix (PWM) for each of those clusters was
calculated and used to generate motif logos for the individual clusters, given a big
enough size (Supplementary Fig. 5b). Hamming distances were further used to
build a network: an edge was defined between two nodes (significant variable
sequences) when the distance between the sequences was only 1 nucleotide. With
this, we created an adjacency matrix and identified communities of nodes based on
the edge betweenness algorithm (igraph35), identifying trends in the direction of
fold changes within and between communities (Supplementary Fig. 6). Predicted
fold structure of every sequence and minimum free energy (MFE) of the predicted
structure was calculated using RNAfold 2.3.5 of the ViennaRNA package36. A
complete description of the pipeline can be found in the README.md available in
GitHub.
Validation of construct functionality in cell culture. Selected sequences of
potential hit constructs were tested for their ability to regulated reporter gene
expression in eGFP or dual-luciferase assays in HEK293 and HeLa cells, respec-
tively. For Tet-hammerhead and Gua-riboswitch construct validation, 25,000
HEK293 cells were seeded per well of a 96-well plate the day before transfection.
Using the Lipofectamine-3000 kit (Thermo Fisher Scientific), cells were transfected
with 35 ng of plasmid DNA and subsequently supplied with stimulation media
containing increasing amounts of tetracycline. In case of Gua-responsive con-
structs, cells were calcium-phosphate transfected by mixing 70 ng DNA with 10 µL
300 mmol/l CaCl2 and 10 µL 2× HBS buffer (50 mmol/l HEPES, 280 mmol/l NaCl,
1.5 mmol/l Na2HPO4) and adding 20 µL of this mix per well of a 96-well plate3.
The media was changed to Gua-containing media approximately 4 h after addition
of the transfection mix. 24 h after transfection, eGFP fluorescence was measured
using a Molecular Devices SpectraMax i3x fluorescence reader. For Twister ribo-
zyme validation, 20,000 HeLa cells per well were seeded in a 96-well plate. The next
day, plasmids were transfected into the cells using Lipofectamine 3000 according
to the manufacturer’s instructions. After 4 h, medium was exchanged to medium
with or without Tet. 24 h after transfection, the Dual-Glo Luciferase Assay (Pro-
mega) was performed. The activity of the hRluc was normalized to the activity of
the hluc.
Statistics. Statistical calculations were performed using GraphPad Prism V7.03
and R version 3.3.2 (2016-10-31).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request. The raw sequencing data for the riboswitch screens have
been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO
Series accession number GSE143466 [https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE143466]. The source data underlying Figs. 2b–g, 3b–e, 4b–e, 5a–d and 6c–f are
provided as a Source Data file.
Code availability
The full computational processing pipeline is available via GitHub at [https://www.
github.com/bi-compbio/riboswitch-pipeline/].
Received: 9 June 2019; Accepted: 14 January 2020;
References
1. Groher, F. & Suess, B. Synthetic riboswitches—a tool comes of age. Biochim.
Biophys. Acta. 1839, 964–973 (2014).
2. Ketzer, P., Haas, S. F., Engelhardt, S., Hartig, J. S. & Nettelbeck, D. M. Synthetic
riboswitches for external regulation of genes transferred by replication-deficient
and oncolytic adenoviruses. Nucleic Acids Res. 40, e167 (2012).
3. Strobel, B. et al. Riboswitch-mediated Attenuation of transgene cytotoxicity
increases adeno-associated virus vector yields in HEK-293 cells. Mol. Ther. 23,
1582–1591 (2015).
4. Beilstein, K., Wittmann, A., Grez, M. & Suess B. Conditional control of
mammalian gene expression by tetracycline-dependent hammerhead
ribozymes. ACS Synth. Biol. 4, 526–534. (2014).
5. Wurmthaler, L. A., Sack, M., Gense, K., Hartig, J. S. & Gamerdinger, M. A
tetracycline-dependent ribozyme switch allows conditional induction of gene
expression in Caenorhabditis elegans. Nat. Commun. 10, 491 (2019).
6. Zhong G., Wang H., Bailey C. C., Gao G. & Farzan M. Rational design of
aptazyme riboswitches for efficient control of gene expression in mammalian
cells. Elife 5, e18858 (2016).
7. Reid, C. A., Nettesheim, E. R., Connor, T. B. & Lipinski, D. M. Development of
an inducible anti-VEGF rAAV gene therapy strategy for the treatment of wet
AMD. Sci. Rep. 8, 11763 (2018).
8. Vogel M., Weigand J. E., Kluge B., Grez M. & Suess B. A small, portable RNA
device for the control of exon skipping in mammalian cells. Nucleic Acids Res.
46, e48 (2018).
9. Mou, H. et al. Conditional regulation of gene expression by ligand-induced
occlusion of a microRNA target sequence. Mol. Ther. 26, 1277–1286 (2018).
10. Townshend, B., Kennedy, A. B., Xiang, J. S. & Smolke, C. D. High-throughput
cellular RNA device engineering. Nat. Methods 12, 989–994 (2015).
11. Nomura, Y., Chien, H. C. & Yokobayashi, Y. Direct screening for ribozyme
activity in mammalian cells. Chem. Commun. (Camb.) 53, 12540–12543 (2017).
12. Nomura, Y., Zhou, L., Miu, A. & Yokobayashi, Y. Controlling mammalian
gene expression by allosteric hepatitis delta virus ribozymes. ACS Synth. Biol.
2, 684–689 (2013).
13. Stifel J., Spöring M. & Hartig J. S. Expanding the toolbox of synthetic riboswitches
with guanine-dependent aptazymes. Synth. Biol. 4, ysy022 (2019).
14. Berens, C., Thain, A. & Schroeder, R. A tetracycline-binding RNA aptamer.
Bioorg. Med Chem. 9, 2549–2556 (2001).
15. Yen, L. et al. Exogenous control of mammalian gene expression through
modulation of RNA self-cleavage. Nature 431, 471–476 (2004).
16. Jimenez, R. M., Polanco, J. A. & Lupták, A. Chemistry and biology of self-
cleaving ribozymes. Trends Biochem Sci. 40, 648–661 (2015).
17. Felletti, M., Stifel, J., Wurmthaler, L. A., Geiger, S. & Hartig, J. S. Twister
ribozymes as highly versatile expression platforms for artificial riboswitches.
Nat. Commun. 7, 12834 (2016).
18. Yokobayashi, Y. Aptamer-based and aptazyme-based riboswitches in
mammalian cells. Curr. Opin. Chem. Biol. 52, 72–78 (2019).
19. Wong, R. S., Chen, Y. Y. & Smolke, C. D. Regulation of T cell proliferation with
drug-responsive microRNA switches. Nucleic Acids Res 46, 1541–1552 (2018).
20. Fortes, P. et al. Inhibiting expression of specific genes in mammalian cells with 5′
end-mutated U1 small nuclear RNAs targeted to terminal exons of pre-mRNA.
Proc. Natl Acad. Sci. USA 100, 8264–8269 (2003).
21. Beckley, S. A. et al. Reduction of target gene expression by a modified
U1 snRNA. Mol. Cell Biol. 21, 2815–2825 (2001).
22. Arnold, C. D. et al. Genome-wide quantitative enhancer activity maps
identified by STARR-seq. Science 339, 1074–1077 (2013).
23. Kobori, S. & Yokobayashi, Y. Analyzing and tuning ribozyme activity by deep
sequencing to modulate gene expression level in mammalian cells. ACS Synth.
Biol. 7, 371–376 (2018).
24. Kobori, S., Nomura, Y., Miu, A. & Yokobayashi, Y. High-throughput assay
and engineering of self-cleaving ribozymes by sequencing. Nucleic Acids Res.
43, e85 (2015).
25. Kobori, S., Takahashi, K. & Yokobayashi, Y. Deep sequencing analysis of aptazyme
variants based on a pistol ribozyme. ACS Synth. Biol. 6, 1283–1288 (2017).
26. Xiang, J. S. et al. Massively parallel RNA device engineering in mammalian
cells with RNA-Seq. Nat. Commun. 10, 4327 (2019).
27. Xiao, Y. et al. A novel significance score for gene selection and ranking.
Bioinformatics 30, 801–807 (2014).
28. Wittmann, A. & Suess, B. Selection of tetracycline inducible self-cleaving
ribozymes as synthetic devices for gene regulation in yeast. Mol. Biosyst. 7,
2419–2427 (2011).
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14491-x ARTICLE
NATURE COMMUNICATIONS |          (2020) 11:714 | https://doi.org/10.1038/s41467-020-14491-x | www.nature.com/naturecommunications 11
29. Ausländer, S., Ketzer, P. & Hartig, J. S. A ligand-dependent hammerhead
ribozyme switch for controlling mammalian gene expression. Mol. Biosyst. 6,
807–814 (2010).
30. Kienle, E. et al. Engineering and evolution of synthetic adeno-associated virus
(AAV) gene therapy vectors via DNA family shuffling. J. Vis. Exp. https://
www.jove.com/video/3819/engineering-evolution-synthetic-adeno-associated-
virus-aav-gene (2012).
31. Grimm, D. & Büning, H. Small but increasingly mighty: latest advances in AAV
vector research, design, and evolution. Hum. Gene Ther. 28, 1075–1086 (2017).
32. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor
package for differential expression analysis of digital gene expression data.
Bioinformatics 26, 139–140 (2010).
33. R Core Team. R: A language and environment for statistical computing. R
Foundation for Statistical Computing. Vienna, Austria. https://www.r-project.
org/ (2018).
34. Ou, J., Wolfe, S. A., Brodsky, M. H. & Zhu, L. J. motifStack for the analysis of
transcription factor binding site evolution. Nat. Methods 15, 8–9 (2018).
35. Csardi, G. & Nepusz, T. The igraph software package for complex network
research. InterJournal, Complex Systems 1695, http://igraph.org (2006).
36. Lorenz, R. et al. ViennaRNA Package 2.0. Algorithms Mol. Biol. 6, 26 (2011).
Acknowledgements
The authors thank Tobias Hildebrandt, Coralie Viollet and Dagmar Knebel for sup-
porting amplicon-sequencing and Astrid Joachimi (University of Konstanz) for excellent
technical assistance.
Author contributions
B.S., M.S., J.S.H. and S.K. conceived the study and designed all experiments. B.S., M.S.,
D.B. and W.R. performed and analyzed experiments. H.K. and S.P. developed the
computational analysis pipeline and conducted additional customized analyses. B.S., H.K.
and S.K. wrote the manuscript draft. All authors edited and contributed to the final
version of the manuscript.
Competing interests
All authors listed, except from M.S. and J.S.H., are employees of Boehringer Ingelheim
Pharma GmbH & Co. KG.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41467-
020-14491-x.
Correspondence and requests for materials should be addressed to S.K.
Peer review information Nature Communications thanks Donald Burke and the other,
anonymous, reviewer(s) for their contribution to the peer review of this work. Peer
reviewer reports are available.
Reprints and permission information is available at http://www.nature.com/reprints
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative
Commons license, and indicate if changes were made. The images or other third party
material in this article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not included in the
article’s Creative Commons license and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from
the copyright holder. To view a copy of this license, visit http://creativecommons.org/
licenses/by/4.0/.
© The Author(s) 2020
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-14491-x
12 NATURE COMMUNICATIONS |          (2020) 11:714 | https://doi.org/10.1038/s41467-020-14491-x | www.nature.com/naturecommunications
